G

Guardian Bio

3 employees

Guardian Bio is centred on developing a personalised cell therapy based on dendritic cells.

Basic info

biotechnology research

Biotechnology

Health Care

2022

G

Guardian Bio raised undisclosed on August 22, 2022

Investors: Y Combinator